Desk›Healthcare› Solara Active Pharma Sciences Ltd
Solara Active Pharma Sciences Ltd
BSE 541540 · NSE SOLARA · ISIN INE624Z01016 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹621.10
+1.60%
BSE close, 28 August 2026
₹2,968.52 cr
4.8 cr shares · Micro cap
₹1,507.66 cr
as published
-3,881.9× · 2.75×
EPS ₹-0.16 · BV ₹225.85
1,368.98 / -7.24
₹ cr, as filed
27
5 selected · 19%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -12.7% |
|---|---|
| Against 52-week low | +46.9% |
| Day change | +1.60% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-0.16 |
|---|---|
| Price / earnings | -3,881.88× |
| Price / book | 2.75× |
| Book value — derived, price ÷ P/B | ₹225.85 |
| Return on equity | -0.07% |
| Operating margin | 16.75% |
| Net margin | 4.45% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -0.07%
- ROE as published
- -0.07%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 381.60 | 16.99 | 3.67 | 16.75% | 4.45% |
| Mar-26 · Q | 387.29 | 9.73 | 2.23 | 16.22% | 2.51% |
| FY25-26 | 1,368.98 | -7.24 | -1.64 | 13.64% | -0.53% |
Quarter on quarter
- Revenue, quarter on quarter
- -1.5%
- Net profit, quarter on quarter
- +74.6%
- Operating margin, quarter on quarter
- +53 bps
Disclosure profile 27 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Press Release | 2 |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Results | 1 |
| Selected sub-total | 5 |
| Procedural | |
| General | 6 |
| AGM / EGM | 3 |
| Newspaper Publication | 3 |
| ESOP Allotment | 2 |
| Analyst / Investor Meet | 1 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Monitoring Agency | 1 |
| Other Update | 1 |
| Trading Window | 1 |
| Procedural sub-total | 22 |
| Total | 27 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
27 filings · 5 selected · busiest 2026-07-23
Filing rhythm · the twelve most recent
2026-08-242026-10-09
SelectedProcedural
Filings
27 in the window · 14 earlier on record
-
9 October 2026 ·
Update On Rights Issue - Final Reminder Cum Forfeiture Notice
Update on approval of Final Reminder cum Forfeiture Notice for payment of outstanding call money.
Company Update / General View filing →
-
9 October 2026 ·
Board Meeting Intimation for Quarter And Half Year Ended September 30, 2026
Solara Active Pharma Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2026 ,inter alia, to consider and approve unaudited financial ....
Board Meeting / Board Meeting View filing →
-
9 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Solara Active Pharma Sciences Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended ....
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
25 September 2026 ·
Closure of Trading Window
Intimation regarding Closure of Trading window for the quarter ended September 30, 2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
22 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Solara Active Pharma Sciences Limited has informed the exchange regarding the Voting Results and the Scrutinizer's report of the Ninth Annual General Meeting
AGM/EGM / AGM View filing →
-
18 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Solara Active Pharma Sciences Limited has informed the Exchange regarding the Proceedings of Ninth Annual General Meeting held on September 18, 2026.
AGM/EGM / AGM View filing →
-
28 August 2026 ·
Intimation In Connection With The Receipt Of Rectification Order
Solara Active Pharma Sciences Limited has informed the exchange about intimation in connection with the receipt of Rectification Order
Company Update / General View filing →
-
26 August 2026 ·
Newspaper Publication
Newspaper publication regarding the completion of dispatch of 9th AGM Notice and Annual report
Company Update / Newspaper Publication View filing →
-
25 August 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Reporting for the financial year 2025-26.
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
25 August 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for the financial year ended March 31, 2026
Others / Reg. 34 (1) Annual Report View filing →
-
25 August 2026 ·
Notice Of The Ninth Annual General Meeting
Solara Active Pharma Sciences Limited has informed the exchange about the dispatch of Notice of Ninth Annual General Meeting (AGM) of the Company scheduled to be held on Friday, September 18, 2026
AGM/EGM / AGM View filing →
-
24 August 2026 ·
Newspaper Publication
Solara Active Pharma Sciences Limited has informed the stock exchange regarding the Newspaper publication with respect to the Ninth Annual General Meeting.
Company Update / Newspaper Publication View filing →
-
19 August 2026 ·
Conversion Of Partly Paid-Up Rights Equity Shares Into Fully Paid-Up Equity Shares In Relation To The Rights Issue By The Company, Upon Receipt Of The Call Monies, As Applicable
Conversion of Partly paid-up Rights Equity Shares into fully paid-up Equity shares in relation to the rights issue by the Company, upon receipt of Call Monies, as applicable.
Company Update / General View filing →
-
18 August 2026 ·
Allotment of ESOP / ESPS
Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 equity shares pursuant to exercise of ESOP options
Company Update / Allotment of ESOP / ESPS View filing →
-
7 August 2026 ·
Update With Respect To Our Intimation Dated July 23, 2026, Regarding Appointment Of CIO And SMP Of The Company.
Solara Active Pharma Sciences Limited has informed the exchange regarding the update with respect to our intimation dated July 23, 2026, regarding appointment of Chief Information Officer ....
Company Update / General View filing →
-
29 July 2026 ·
Earnings Call Transcript
Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended June 30, 2026
Company Update / Earnings Call Transcript View filing →
-
24 July 2026 ·
Newspaper Publication
Solara Active Pharma Sciences Limited has informed the exchange about the copy of the Newspaper publication providing extract of the unaudited Financial Results (Standalone and Consolidated) ....
Company Update / Newspaper Publication View filing →
-
24 July 2026 ·
Submission Of Machine Readable Copy Of Financial Results For The Quarter Ended June 30, 2026
Solara Active Pharma Sciences Limited has informed the exchange regarding submission of Machine Readable copy of Financial results for the quarter ended June 30, 2026
Company Update / General View filing →
-
23 July 2026 ·
Analyst / Investor Meet - Outcome
Solara Active Pharma Sciences Limited has informed the exchange about the Audio Recording of the Q1 FY 27 Earnings call held on July 23, 2026, at 16.00 IST
Company Update / Analyst / Investor Meet View filing →
-
23 July 2026 ·
Monitoring Agency Report
Monitoring Agency Report for the quarter ended June 30, 2026
Company Update / Monitoring Agency Report View filing →
-
23 July 2026 ·
Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended June 30, 2026.
Solara Active Pharma Sciences Limited has informed the exchange that there is no Deviation and Variation of funds raised through Rights Issue for the quarter ended June 30, 2026
Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
-
23 July 2026 ·
Allotment of ESOP / ESPS
Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 Equity Shares pursuant to exercise of ESOP options.
Company Update / Allotment of ESOP / ESPS View filing →
-
23 July 2026 ·
Intimation About Appointment Of Chief Information Officer (CIO)
Solara Active Pharma Sciences Limited has informed the exchange regarding the appointment of Mr. Ajit Manocha as Chief Information Officer (CIO) and designated him as Senior Management ....
Company Update / General View filing →
-
23 July 2026 ·
Press Release / Media Release
Solara Active Pharma Sciences Limited has informed the exchange regarding the Press Release dated July 23, 2026, titled- Solara reports strong Q1'27 Base business performance with continued ....
Company Update / Press Release / Media Release View filing →
-
23 July 2026 ·
Press Release / Media Release
Solara Active Pharma Sciences Limited has informed the exchange regarding the Press Release dated July 23, 2026, titled - Solara reports Strong Q1'27 Base business performance with Continued ....
Company Update / Press Release / Media Release View filing →
-
23 July 2026 ·
Unaudited Financial Results For The Quarter Ended June 30, 2026
Solara Active Pharma Sciences Limited has informed the exchange regarding, inter alia, to consider and approve the unaudited Standalone and Consolidated financial results for the quarter ....
Result / Financial Results View filing →
-
23 July 2026 ·
Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30, 2026.
Solara Active Pharma Sciences Limited has informed the exchange regarding, inter alia, to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ....
Board Meeting / Outcome of Board Meeting View filing →
RSS feed for Solara Active Pharma Sciences Ltd · the 50 most recent filings